{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:25:20Z","timestamp":1791192320367,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11011-011-9274-6","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T02:46:13Z","timestamp":1324608373000},"page":"1-5","source":"Crossref","is-referenced-by-count":135,"title":["Morphine metabolism, transport and brain disposition"],"prefix":"10.1007","volume":"27","author":[{"given":"Simona","family":"De Gregori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"De Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmina Nadia","family":"Ranzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Minella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Regazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,24]]},"reference":[{"issue":"11","key":"9274_CR1","first-page":"937","volume":"76","author":"M Allegri","year":"2010","unstructured":"Allegri M, De Gregori M, Niebel T et al (2010) Pharmacogenetics and postoperative pain: a new approach to improve acute pain management. Minerva Anestesiol 76(11):937\u201344","journal-title":"Minerva Anestesiol"},{"key":"9274_CR2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","volume":"86","author":"F Bourasset","year":"2003","unstructured":"Bourasset F, Cisternino S, Temsamani J, Scherrmann JM (2003) Evidence for an active transport of morphine-6-\u03b2-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem 86:1564\u20131567","journal-title":"J Neurochem"},{"key":"9274_CR3","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/sj.bjp.0704406","volume":"134","author":"MR Bouw","year":"2001","unstructured":"Bouw MR, Tunblad K, Hammarlund-Udenaes M (2001) Blood Brain Barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats \u2013 pharmacokinetic\/pharmacodynamic modelling. Br J Pharmacol 134:1796\u20131804","journal-title":"Br J Pharmacol"},{"key":"9274_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","volume":"83","author":"D Campa","year":"2008","unstructured":"Campa D, Gioia A, Tomei A et al (2008) Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 83:559\u2013566","journal-title":"Clin Pharmacol Ther"},{"key":"9274_CR5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm00108a005","volume":"34","author":"PA Carrupt","year":"1991","unstructured":"Carrupt PA, Testa B, Bechalany A et al (1991) Morphine 6-Glucuronide and Morphine 3-Glucuronide as molecular chameleons with unexpected lipophilicity. J Med Chem 34:1272\u20131275","journal-title":"J Med Chem"},{"key":"9274_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0773.1987.tb01724.x","volume":"60","author":"CB Christensen","year":"1987","unstructured":"Christensen CB, J\u01ffrgensen LN (1987) Morphine-6-glucuronide has high affinity for the opioid receptors. Pharmacol Toxicol 60:75\u201376","journal-title":"Pharmacol Toxicol"},{"key":"9274_CR7","unstructured":"Coffman BL, King CD, Rios GR, Tephly TR (1998) The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26(1):73\u201377"},{"key":"9274_CR8","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/0006-2952(89)90625-4","volume":"38","author":"MW Coughtrie","year":"1989","unstructured":"Coughtrie MW, Ask B, Rane A et al (1989) The enantioselective glucuronidation of morphine in rats and humans. Biochem Pharmacol 38:3273\u20133280","journal-title":"Biochem Pharmacol"},{"key":"9274_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004647-200002000-00020","volume":"20","author":"C Dagenais","year":"2000","unstructured":"Dagenais C, Rousselle C, Pollack GM, Scherrmann JM (2000) Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. J Cereb Blood Flow Metab 20:381\u2013386","journal-title":"J Cereb Blood Flow Metab"},{"key":"9274_CR10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.43.100901.140204","volume":"43","author":"AG Boer De","year":"2003","unstructured":"De Boer AG, van der Sandt ICJ, Gaillard PJ (2003) The role of drug transporters at the Blood-Brain-Barrier. Annu Rev Pharmacol Toxicol 43:629\u2013656","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9274_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1208\/s12248-009-9126-z","volume":"11","author":"YM Di","year":"2009","unstructured":"Di YM, Chan E, Wei MQ et al (2009) Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes. AAPS J 11:469\u2013480","journal-title":"AAPS J"},{"issue":"2","key":"9274_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-009-1029-2","volume":"65","author":"K Fujita","year":"2010","unstructured":"Fujita K, Ando Y, Yamamoto W et al (2010) Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother Pharmacol Jan 65(2):251\u20138","journal-title":"Cancer Chemother Pharmacol Jan"},{"key":"9274_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00228-002-0490-1","volume":"58","author":"M Holthe","year":"2002","unstructured":"Holthe M, Klepstad P, Zahlsen K et al (2002) Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1 *28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58:353\u2013356","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"9274_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/FPC.0b013e3283037fe4","volume":"18","author":"F Innocenti","year":"2008","unstructured":"Innocenti F, Liu W, Fackenthal D, Ram\u00edrez J, Chen P, Ye X, Wu X, Zhang W, Mirkov S, Das S, Cook E Jr, Ratain MJ (2008) Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 18(8):683\u201397","journal-title":"Pharmacogenet Genomics."},{"key":"9274_CR15","unstructured":"Johansson BB, Nordborg C, Westergren I (1990) Neuronal injury after transient opening of the blood-brain barrier: modifying factors. Johansson BB, Owman CG, Widner H. Pathophysiology of the blood-brain barrier. Amsterdam Elsevier 145\u2013157"},{"issue":"2","key":"9274_CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","volume":"11","author":"J L\u00f6tsch","year":"2005","unstructured":"L\u00f6tsch J, Geisslinger G (2005) Are \u03bc-opioid receptor polymorphisms important for clinical opioid therapy? TRENDS Mol Med 11(2):82\u201389","journal-title":"TRENDS Mol Med"},{"key":"9274_CR17","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/S0024-3205(00)00569-5","volume":"66","author":"J L\u00f6tsch","year":"2001","unstructured":"L\u00f6tsch J, Tegeder I, Angst MS, Geisslinger G (2001) Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test. Life Sci 66:2393\u20132403","journal-title":"Life Sci"},{"key":"9274_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1471-4159.2002.01177.x","volume":"83","author":"J L\u00f6tsch","year":"2002","unstructured":"L\u00f6tsch J, Schmidt R, Vetter G et al (2002a) Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein. J Neurochem 83:241\u2013248","journal-title":"J Neurochem"},{"key":"9274_CR19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","volume":"97","author":"J L\u00f6tsch","year":"2002","unstructured":"L\u00f6tsch J, Zimmermann M, Darimont J (2002b) Does the A118G polymorphism at the \u03bc-opioid receptor gene protect against morphine-6-glucuronide toxicity? Anesthesiology 97:814\u2013819","journal-title":"Anesthesiology"},{"key":"9274_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-0173(91)90020-9","volume":"16","author":"A Minn","year":"1991","unstructured":"Minn A, Ghersi-Egea JF, Perrin R et al (1991) Drug metabolizing enzyme in the brain and cerebral microvessels. Brain Res Rev 16:65\u201382","journal-title":"Brain Res Rev"},{"key":"9274_CR21","first-page":"234","volume":"70","author":"K Murakami","year":"1997","unstructured":"Murakami K, Kondo T, Chan PH (1997) Blood-brain barrier disruption: edema formation and apoprotic neuronal death following cold injury. Acta Neurochir Suppl (Wien) 70:234\u2013236","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"9274_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","volume":"47","author":"R Osborne","year":"1990","unstructured":"Osborne R, Joel S, Trew D, Slevin M (1990) Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 47:12","journal-title":"Clin Pharmacol Ther"},{"key":"9274_CR23","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","volume":"91","author":"R Polt","year":"1994","unstructured":"Polt R, Porreca F, Szabo LZ et al (1994) Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci USA 91:7114\u20137118","journal-title":"Proc Natl Acad Sci USA"},{"key":"9274_CR24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000542-200503000-00008","volume":"102","author":"R Romberg","year":"2005","unstructured":"Romberg R, Olofsen E, Bijil H (2005) Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid induced respiratory depression despite reduced analgesic response. Anesthesiology 102:522\u2013530","journal-title":"Anesthesiology"},{"key":"9274_CR25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1469-1809.2006.00260.x","volume":"70","author":"K Sai","year":"2006","unstructured":"Sai K, Itoda M, Saito Y et al (2006) Genetic variations and haplotype structures of the ABCB1 gene in a Japanese population: an expanded haplotype block covering the distal promoter region, andassociated ethnic differences. Ann Hum Genet 70:605\u2013622","journal-title":"Ann Hum Genet"},{"key":"9274_CR26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","volume":"27","author":"MT Smith","year":"2000","unstructured":"Smith MT (2000) Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 27:524\u2013528","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9274_CR27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/dmd.31.9.1086","volume":"31","author":"A Stone","year":"2003","unstructured":"Stone A, Mackenzie P, Galetin A et al (2003) Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7. Drug Metab Dispos 31:1086\u20131089","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"9274_CR28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0006-2952(01)00761-4","volume":"62","author":"C Ulens","year":"2001","unstructured":"Ulens C, Baker L, Ratka A et al (2001) Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies. Biochem Pharmacol 62(9):1273\u20131282","journal-title":"Biochem Pharmacol"},{"key":"9274_CR29","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.bjp.0703759","volume":"131","author":"R Xie","year":"2000","unstructured":"Xie R, Bouw M, Hammarlund-Udenaes M (2000) Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport. Br J Pharmacol 131:1784\u20131792","journal-title":"Br J Pharmacol"},{"key":"9274_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2131\/jts.28.395","volume":"28","author":"H Yamada","year":"2003","unstructured":"Yamada H, Ishii K, Ishii Y et al (2003) Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J Toxicol Sci 28:395\u2013401","journal-title":"J Toxicol Sci"},{"key":"9274_CR31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0006-2952(73)90320-1","volume":"22","author":"H Yoshimura","year":"1973","unstructured":"Yoshimura H, Ida S, Oguri K, Tsukamoto H (1973) Biochemical basis for analgesic activity of morphine-6-glucuronide. Penetration of morphine-6-glucuronide in the brain of rats. Biochem Pharmacol 22:1423\u20131430","journal-title":"Biochem Pharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11011-011-9274-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:45:18Z","timestamp":1497959118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-011-9274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9274"],"URL":"https:\/\/doi.org\/10.1007\/s11011-011-9274-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,24]]}}}